Serious Adverse Event (SAE) Management in Clinical Trials: Complete Guide
Serious Adverse Events (SAEs) include any untoward medical occurrence that results in death, is life-threatening, requires hospitalization, leads to persistent or significant disability, or causes a congenital anomaly. Effective SAE management ensures rapid identification, assessment, reporting, and mitigation of risks during clinical trials, protecting participants and maintaining study integrity.
Click to read the full article.